Bilan Wang
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 10%
Papers in
-
- RNA Interference and Gene Delivery 7
- Protein Degradation and Inhibitors 2
-
- Immunotherapy and Immune Responses 7
- Immune cells in cancer 3
- Co-authors
- Xiang Gao (12 shared papers)Yuzhu Hu (10 shared papers)Yan Teng (2 shared papers)Junli Chen (2 shared papers)Jianguo Xu (1 shared paper)Yongzhong Cheng (1 shared paper)Shiqi Hu (1 shared paper)Haoyuan Wang (1 shared paper)
- Journals
- Journal of Biomedical Nanotechnology (2 papers)Oncotarget (2 papers)Signal Transduction and Targeted Therapy (2 papers)Small Methods (1 paper)ACS Central Science (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Bilan Wang
16 papers receiving 644 citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Biomaterials 187
- Molecular Medicine 41
- Immunology 141
- Biomedical Engineering 248
- Oncology 148
Countries citing papers authored by Bilan Wang
This map shows the geographic impact of Bilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilan Wang more than expected).
Fields of papers citing papers by Bilan Wang
This network shows the impact of papers produced by Bilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilan Wang. The network helps show where Bilan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bilan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Current advance of nanotechnology in diagnosis and treatment for malignant tumors Hit paper breakdown → | 2024 | 238 |
| 2 | 2019 | 54 | |
| 3 | 2017 | 51 | |
| 4 | 2020 | 47 | |
| 5 | 2024 | 43 | |
| 6 | 2018 | 38 | |
| 7 | 2023 | 37 | |
| 8 | 2021 | 32 | |
| 9 | 2017 | 25 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 17 | |
| 12 | 2021 | 15 | |
| 13 | 2017 | 15 | |
| 14 | 2019 | 12 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2025 | 0 | |
| 18 | 2020 | 0 |
About Bilan Wang
Bilan Wang is a scholar working on Molecular Biology, Immunology, Oncology, Biomedical Engineering and Biomaterials, having authored 18 papers that have together received 659 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers), Immune cells in cancer (3 papers), Protein Degradation and Inhibitors (2 papers), Curcumin's Biomedical Applications (2 papers), Cancer Research and Treatments (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Biomaterials (187 citations), Molecular Medicine (41 citations), Immunology (141 citations), Biomedical Engineering (248 citations) and Oncology (148 citations). Bilan Wang has collaborated with scholars based in China and United States. Frequent co-authors include Xiang Gao, Yuzhu Hu, Yan Teng, Junli Chen, Jianguo Xu, Yongzhong Cheng, Shiqi Hu, Haoyuan Wang, Kaiyu Wang and Ting Yu. Their work appears in journals such as Journal of Biomedical Nanotechnology, Oncotarget, Signal Transduction and Targeted Therapy, Small Methods and ACS Central Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.